{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T12:30:50Z","timestamp":1773232250269,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00125-025-06405-7","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T12:40:55Z","timestamp":1744375255000},"page":"1315-1328","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Alterations in cerebral perfusion and substrate metabolism in type 2 diabetes: interactions with APOE-\u03b54"],"prefix":"10.1007","volume":"68","author":[{"given":"Martin","family":"Schain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edvin","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iina","family":"Laitinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Fr\u00f6d\u00e9n L\u00f6wenmark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Lubberink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Gummesson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torsten","family":"Danfors","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pirjo","family":"Nuutila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell","family":"Esterline","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Oscarsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"Heurling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,11]]},"reference":[{"key":"6405_CR1","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3389\/fnins.2018.00383","volume":"12","author":"S Chatterjee","year":"2018","unstructured":"Chatterjee S, Mudher A (2018) Alzheimer\u2019s disease and type 2 diabetes: a critical assessment of the shared pathological traits. Front Neurosci 12:383. https:\/\/doi.org\/10.3389\/fnins.2018.00383","journal-title":"Front Neurosci"},{"issue":"6","key":"6405_CR2","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.biopsych.2009.02.013","volume":"67","author":"LA Profenno","year":"2010","unstructured":"Profenno LA, Porsteinsson AP, Faraone SV (2010) Meta-analysis of Alzheimer\u2019s disease risk with obesity, diabetes, and related disorders. Biol Psychiatry 67(6):505\u2013512. https:\/\/doi.org\/10.1016\/j.biopsych.2009.02.013","journal-title":"Biol Psychiatry"},{"key":"6405_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.arr.2016.01.002","volume":"30","author":"L Pini","year":"2016","unstructured":"Pini L, Pievani M, Bocchetta M et al (2016) Brain atrophy in Alzheimer\u2019s disease and aging. Ageing Res Rev 30:25\u201348. https:\/\/doi.org\/10.1016\/j.arr.2016.01.002","journal-title":"Ageing Res Rev"},{"issue":"2","key":"6405_CR4","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","volume":"7","author":"E Nichols","year":"2022","unstructured":"Nichols E, Steinmetz JD, Vollset SE et al (2022) Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health 7(2):e105\u2013e125. https:\/\/doi.org\/10.1016\/S2468-2667(21)00249-8","journal-title":"Lancet Public Health"},{"key":"6405_CR5","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.diabres.2019.07.004","volume":"154","author":"JY Kim","year":"2019","unstructured":"Kim JY, Ku YS, Kim HJ et al (2019) Oral diabetes medication and risk of dementia in elderly patients with type 2 diabetes. Diabetes Res Clin Pract 154:116\u2013123. https:\/\/doi.org\/10.1016\/j.diabres.2019.07.004","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"6405_CR6","doi-asserted-by":"publisher","first-page":"972","DOI":"10.2337\/dc18-1399","volume":"42","author":"EC McIntosh","year":"2019","unstructured":"McIntosh EC, Nation DA (2019) Importance of treatment status in links between type 2 diabetes and Alzheimer\u2019s disease. Diabetes Care 42(5):972\u2013979. https:\/\/doi.org\/10.2337\/dc18-1399","journal-title":"Diabetes Care"},{"key":"6405_CR7","doi-asserted-by":"publisher","first-page":"102689","DOI":"10.1016\/j.eclinm.2024.102689","volume":"73","author":"B Tang","year":"2024","unstructured":"Tang B, Sj\u00f6lander A, Wastesson JW et al (2024) Comparative effectiveness of glucagon-like peptide-1 agonists, dipeptidyl peptidase-4 inhibitors, and sulfonylureas on the risk of dementia in older individuals with type 2 diabetes in Sweden: an emulated trial study. EClinicalMedicine 73:102689. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102689","journal-title":"EClinicalMedicine"},{"issue":"2","key":"6405_CR8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2337\/dc22-1705","volume":"46","author":"C-Y Wu","year":"2023","unstructured":"Wu C-Y, Iskander C, Wang C et al (2023) Association of sodium-glucose cotransporter 2 inhibitors with time to dementia: a population-based cohort study. Diabetes Care 46(2):297\u2013304. https:\/\/doi.org\/10.2337\/dc22-1705","journal-title":"Diabetes Care"},{"issue":"8","key":"6405_CR9","doi-asserted-by":"publisher","first-page":"e209805","DOI":"10.1212\/WNL.0000000000209805","volume":"103","author":"HK Kim","year":"2024","unstructured":"Kim HK, Biessels GJ, Yu MH et al (2024) SGLT2 inhibitor use and risk of dementia and Parkinson disease among patients with type 2 diabetes. Neurology 103(8):e209805. https:\/\/doi.org\/10.1212\/WNL.0000000000209805","journal-title":"Neurology"},{"key":"6405_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/bs.irn.2020.02.011","volume":"154","author":"K Heurling","year":"2020","unstructured":"Heurling K, Johansson E, Leuzy A (2020) Disturbances in brain energy metabolism in insulin resistance and diabetes and Alzheimer\u2019s disease - Learnings from brain imaging biomarkers. Int Rev Neurobiol 154:111\u2013130. https:\/\/doi.org\/10.1016\/bs.irn.2020.02.011","journal-title":"Int Rev Neurobiol"},{"issue":"1","key":"6405_CR11","doi-asserted-by":"publisher","first-page":"108572","DOI":"10.1016\/j.celrep.2020.108572","volume":"34","author":"G Qi","year":"2021","unstructured":"Qi G, Mi Y, Shi X, Gu H, Brinton RD, Yin F (2021) ApoE4 impairs neuron-astrocyte coupling of fatty acid metabolism. Cell Rep 34(1):108572. https:\/\/doi.org\/10.1016\/j.celrep.2020.108572","journal-title":"Cell Rep"},{"issue":"9","key":"6405_CR12","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.2337\/db09-0138","volume":"59","author":"A Karmi","year":"2010","unstructured":"Karmi A, Iozzo P, Viljanen A et al (2010) Increased brain fatty acid uptake in metabolic syndrome. Diabetes 59(9):2171\u20132177. https:\/\/doi.org\/10.2337\/db09-0138","journal-title":"Diabetes"},{"issue":"7","key":"6405_CR13","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1111\/dom.13996","volume":"22","author":"E Rebelos","year":"2020","unstructured":"Rebelos E, Hirvonen J, Bucci M et al (2020) Brain free fatty acid uptake is elevated in morbid obesity, and is irreversible 6 months after bariatric surgery: a positron emission tomography study. Diabetes Obes Metab 22(7):1074\u20131082. https:\/\/doi.org\/10.1111\/dom.13996","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"6405_CR14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.pneurobio.2006.12.003","volume":"81","author":"JR Moffett","year":"2007","unstructured":"Moffett JR, Ross B, Arun P, Madhavarao CN, Namboodiri AMA (2007) N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol 81(2):89\u2013131. https:\/\/doi.org\/10.1016\/j.pneurobio.2006.12.003","journal-title":"Prog Neurobiol"},{"issue":"5","key":"6405_CR15","doi-asserted-by":"publisher","first-page":"BSR20180660","DOI":"10.1042\/BSR20180660","volume":"38","author":"X Zhao","year":"2018","unstructured":"Zhao X, Han Q, Gang X, Wang G (2018) Altered brain metabolites in patients with diabetes mellitus and related complications \u2013 evidence from 1H MRS study. Biosci Rep 38(5):BSR20180660. https:\/\/doi.org\/10.1042\/BSR20180660","journal-title":"Biosci Rep"},{"key":"6405_CR16","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3389\/fendo.2020.00216","volume":"11","author":"G Daniele","year":"2020","unstructured":"Daniele G, Campi B, Saba A et al (2020) Plasma N-acetylaspartate is related to age, obesity, and glucose metabolism: effects of antidiabetic treatment and bariatric surgery. Front Endocrinol (Lausanne) 11:216. https:\/\/doi.org\/10.3389\/fendo.2020.00216","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"6405_CR17","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3233\/JAD-2005-8304","volume":"8","author":"EJ Rivera","year":"2005","unstructured":"Rivera EJ, Goldin A, Fulmer N, Tavares R, Wands JR, de la Monte SM (2005) Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer\u2019s disease: Link to brain reductions in acetylcholine. J Alzheimer\u2019s Dis 8(3):247\u2013268. https:\/\/doi.org\/10.3233\/JAD-2005-8304","journal-title":"J Alzheimer\u2019s Dis"},{"key":"6405_CR18","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nrn.2017.48","volume":"18","author":"K Kisler","year":"2017","unstructured":"Kisler K, Nelson AR, Montagne A, Zlokovic BV (2017) Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease. Nat Rev Neurosci 18:419\u2013434. https:\/\/doi.org\/10.1038\/nrn.2017.48","journal-title":"Nat Rev Neurosci"},{"key":"6405_CR19","doi-asserted-by":"publisher","first-page":"102302","DOI":"10.1016\/j.nicl.2020.102302","volume":"27","author":"ACM Chau","year":"2020","unstructured":"Chau ACM, Cheung EYW, Chan KH et al (2020) Impaired cerebral blood flow in type 2 diabetes mellitus \u2013 A comparative study with subjective cognitive decline, vascular dementia and Alzheimer\u2019s disease subjects. Neuroimage Clin 27:102302. https:\/\/doi.org\/10.1016\/j.nicl.2020.102302","journal-title":"Neuroimage Clin"},{"key":"6405_CR20","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S1474-4422(20)30139-3","volume":"19","author":"GJ Biessels","year":"2020","unstructured":"Biessels GJ, Nobili F, Teunissen CE, Sim\u00f3 R, Scheltens P (2020) Understanding multifactorial brain changes in type 2 diabetes: a biomarker perspective. Lancet Neurol 19:699\u2013710. https:\/\/doi.org\/10.1016\/S1474-4422(20)30139-3","journal-title":"Lancet Neurol"},{"issue":"1","key":"6405_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13550-024-01114-5","volume":"14","author":"R Aarnio","year":"2024","unstructured":"Aarnio R, Kirjavainen A, Rajander J et al (2024) New improved radiometabolite analysis method for [18F]FTHA from human plasma: a test-retest study with postprandial and fasting state. EJNMMI Res 14(1):53. https:\/\/doi.org\/10.1186\/s13550-024-01114-5","journal-title":"EJNMMI Res"},{"issue":"2","key":"6405_CR22","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1515\/cclm-2021-0651","volume":"60","author":"J Gobom","year":"2022","unstructured":"Gobom J, Parnetti L, Rosa-Neto P et al (2022) Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid. Clin Chem Lab Med (CCLM) 60(2):207\u2013219. https:\/\/doi.org\/10.1515\/cclm-2021-0651","journal-title":"Clin Chem Lab Med (CCLM)"},{"issue":"1","key":"6405_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/jcbfm.1983.1","volume":"3","author":"CS Patlak","year":"1983","unstructured":"Patlak CS, Blasberg RG, Fenstermacher JD (1983) Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 3(1):1\u20137. https:\/\/doi.org\/10.1038\/jcbfm.1983.1","journal-title":"J Cereb Blood Flow Metab"},{"issue":"10","key":"6405_CR24","doi-asserted-by":"publisher","first-page":"5549","DOI":"10.1007\/s00330-019-06096-w","volume":"29","author":"LA Smith","year":"2019","unstructured":"Smith LA, Melbourne A, Owen D et al (2019) Cortical cerebral blood flow in ageing: effects of haematocrit, sex, ethnicity and diabetes. Eur Radiol 29(10):5549\u20135558. https:\/\/doi.org\/10.1007\/s00330-019-06096-w","journal-title":"Eur Radiol"},{"issue":"5","key":"6405_CR25","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/bpa.12401","volume":"26","author":"S Love","year":"2016","unstructured":"Love S, Miners JS (2016) Cerebral hypoperfusion and the energy deficit in Alzheimer\u2019s disease. Brain Pathol 26(5):607\u2013617. https:\/\/doi.org\/10.1111\/bpa.12401","journal-title":"Brain Pathol"},{"issue":"1","key":"6405_CR26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/jcbfm.2014.173","volume":"35","author":"H Rusinek","year":"2015","unstructured":"Rusinek H, Ha J, Yau PL et al (2015) Cerebral perfusion in insulin resistance and type 2 diabetes. J Cereb Blood Flow Metab 35(1):95\u2013102. https:\/\/doi.org\/10.1038\/jcbfm.2014.173","journal-title":"J Cereb Blood Flow Metab"},{"issue":"12","key":"6405_CR27","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1001\/archneur.60.12.1696","volume":"60","author":"CM Clark","year":"2003","unstructured":"Clark CM, Xie S, Chittams J et al (2003) Cerebrospinal fluid Tau and \u03b2-amyloid. Arch Neurol 60(12):1696. https:\/\/doi.org\/10.1001\/archneur.60.12.1696","journal-title":"Arch Neurol"},{"key":"6405_CR28","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.neubiorev.2016.11.023","volume":"72","author":"N Zhang","year":"2017","unstructured":"Zhang N, Gordon ML, Goldberg TE (2017) Cerebral blood flow measured by arterial spin labeling MRI at resting state in normal aging and Alzheimer\u2019s disease. Neurosci Biobehav Rev 72:168\u2013175. https:\/\/doi.org\/10.1016\/j.neubiorev.2016.11.023","journal-title":"Neurosci Biobehav Rev"},{"issue":"7","key":"6405_CR29","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.3390\/jcm1007153210.3390\/jcm10071532","volume":"10","author":"E Rebelos","year":"2021","unstructured":"Rebelos E, Rinne JO, Nuutila P, Ekblad LL (2021) Brain glucose metabolism in health, obesity, and cognitive decline-does insulin have anything to do with it? A narrative review. J Clin Med 10(7):1532. https:\/\/doi.org\/10.3390\/jcm1007153210.3390\/jcm10071532","journal-title":"J Clin Med"},{"issue":"8","key":"6405_CR30","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.2337\/db12-1460","volume":"62","author":"JJ Tuulari","year":"2013","unstructured":"Tuulari JJ, Karlsson HK, Hirvonen J et al (2013) Weight loss after bariatric surgery reverses insulin-induced increases in brain glucose metabolism of the morbidly obese. Diabetes 62(8):2747\u20132751. https:\/\/doi.org\/10.2337\/db12-1460","journal-title":"Diabetes"},{"issue":"2","key":"6405_CR31","doi-asserted-by":"publisher","first-page":"443","DOI":"10.2337\/db10-0940","volume":"60","author":"J Hirvonen","year":"2011","unstructured":"Hirvonen J, Virtanen KA, Nummenmaa L et al (2011) Effects of insulin on brain glucose metabolism in impaired glucose tolerance. Diabetes 60(2):443\u2013447. https:\/\/doi.org\/10.2337\/db10-0940","journal-title":"Diabetes"},{"issue":"6","key":"6405_CR32","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1212\/WNL.0000000000002950","volume":"87","author":"W Li","year":"2016","unstructured":"Li W, Risacher SL, Huang E, Saykin AJ (2016) Type 2 diabetes mellitus is associated with brain atrophy and hypometabolism in the ADNI cohort. Neurology 87(6):595\u2013600. https:\/\/doi.org\/10.1212\/WNL.0000000000002950","journal-title":"Neurology"},{"issue":"5","key":"6405_CR33","doi-asserted-by":"publisher","first-page":"701","DOI":"10.2967\/jnumed.114.146027","volume":"56","author":"CH Lyoo","year":"2015","unstructured":"Lyoo CH, Ikawa M, Liow JS et al (2015) Cerebellum can serve as a pseudo-reference region in Alzheimer disease to detect neuroinflammation measured with PET radioligand binding to translocator protein. J Nucl Med 56(5):701\u2013706. https:\/\/doi.org\/10.2967\/jnumed.114.146027","journal-title":"J Nucl Med"},{"key":"6405_CR34","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1053\/j.semnuclmed.2020.12.005","volume":"51","author":"N Krishnadas","year":"2021","unstructured":"Krishnadas N, Villemagne VL, Dor\u00e9 V, Rowe CC (2021) Advances in brain amyloid imaging. Semin Nucl Med 51:241\u2013252. https:\/\/doi.org\/10.1053\/j.semnuclmed.2020.12.005","journal-title":"Semin Nucl Med"},{"key":"6405_CR35","doi-asserted-by":"publisher","first-page":"20S","DOI":"10.2967\/JNUMED.121.263196","volume":"63","author":"C Groot","year":"2022","unstructured":"Groot C, Villeneuve S, Smith R, Hansson O, Ossenkoppele R (2022) Tau PET imaging in neurodegenerative disorders. J Nucl Med 63:20S-26S. https:\/\/doi.org\/10.2967\/JNUMED.121.263196","journal-title":"J Nucl Med"},{"issue":"4","key":"6405_CR36","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1152\/physrev.00032.2015","volume":"96","author":"S Kullmann","year":"2016","unstructured":"Kullmann S, Heni M, Hallschmid M, Fritsche A, Preissl H, H\u00e4ring H-U (2016) Brain insulin resistance at the crossroads of metabolic and cognitive disorders in humans. Physiol Rev 96(4):1169\u20131209. https:\/\/doi.org\/10.1152\/physrev.00032.2015","journal-title":"Physiol Rev"},{"issue":"4","key":"6405_CR37","doi-asserted-by":"publisher","first-page":"3506","DOI":"10.3390\/ijms24043506","volume":"24","author":"JH Yoon","year":"2023","unstructured":"Yoon JH, Hwang J, Son SU et al (2023) How can insulin resistance cause Alzheimer\u2019s disease? Int J Mol Sci 24(4):3506. https:\/\/doi.org\/10.3390\/ijms24043506","journal-title":"Int J Mol Sci"},{"key":"6405_CR38","doi-asserted-by":"publisher","first-page":"472459","DOI":"10.1155\/2014\/472459","volume":"2014","author":"A Panov","year":"2014","unstructured":"Panov A, Orynbayeva Z, Vavilin V, Lyakhovich V (2014) Fatty acids in energy metabolism of the central nervous system. Biomed Res Int 2014:472459","journal-title":"Biomed Res Int"},{"key":"6405_CR39","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1038\/jcbfm.2013.128","volume":"33","author":"P Sch\u00f6nfeld","year":"2013","unstructured":"Sch\u00f6nfeld P, Reiser G (2013) Why does brain metabolism not favor burning of fatty acids to provide energy-Reflections on disadvantages of the use of free fatty acids as fuel for brain. J Cereb Blood Flow Metab 33:1493\u20131499. https:\/\/doi.org\/10.1038\/jcbfm.2013.128","journal-title":"J Cereb Blood Flow Metab"},{"issue":"7","key":"6405_CR40","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.4103\/1673-5374.387965","volume":"19","author":"SS Helgud\u00f3ttir","year":"2024","unstructured":"Helgud\u00f3ttir SS, M\u00f8rkholt AS, Lichota J et al (2024) Rethinking neurodegenerative diseases: neurometabolic concept linking lipid oxidation to diseases in the central nervous system. Neural Regen Res 19(7):1437\u20131445. https:\/\/doi.org\/10.4103\/1673-5374.387965","journal-title":"Neural Regen Res"},{"issue":"1","key":"6405_CR41","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13195-017-0250-1","volume":"9","author":"HN Yassine","year":"2017","unstructured":"Yassine HN, Croteau E, Rawat V et al (2017) DHA brain uptake and APOE4 status: a PET study with [1-11C]-DHA. Alzheimers Res Ther 9(1):23. https:\/\/doi.org\/10.1186\/s13195-017-0250-1","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"6405_CR42","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3390\/cells8020182","volume":"8","author":"BC Farmer","year":"2019","unstructured":"Farmer BC, Kluemper J, Johnson LA (2019) Apolipoprotein E4 alters astrocyte fatty acid metabolism and lipid droplet formation. Cells 8(2):182. https:\/\/doi.org\/10.3390\/cells8020182","journal-title":"Cells"},{"issue":"16","key":"6405_CR43","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"LA Farrer","year":"1997","unstructured":"Farrer LA, Cupples LA, Haines JL et al (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278(16):1349\u20131356. https:\/\/doi.org\/10.1001\/jama.1997.03550160069041","journal-title":"JAMA"},{"issue":"1","key":"6405_CR44","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13024-022-00566-4","volume":"17","author":"R Fern\u00e1ndez-Calle","year":"2022","unstructured":"Fern\u00e1ndez-Calle R, Konings SC, Fronti\u00f1\u00e1n-Rubio J et al (2022) APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer\u2019s disease pathology and brain diseases. Mol Neurodegener 17(1):62. https:\/\/doi.org\/10.1186\/s13024-022-00566-4","journal-title":"Mol Neurodegener"},{"issue":"1130","key":"6405_CR45","doi-asserted-by":"publisher","first-page":"20200810","DOI":"10.1259\/bjr.20200810","volume":"95","author":"X Zhang","year":"2022","unstructured":"Zhang X, Ogihara T, Zhu M et al (2022) Effect of metformin on 18F-fluorodeoxyglucose uptake and positron emission tomographic imaging. Br J Radiol 95(1130):20200810. https:\/\/doi.org\/10.1259\/bjr.20200810","journal-title":"Br J Radiol"},{"key":"6405_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/694326","volume":"2014","author":"Y-C Huang","year":"2014","unstructured":"Huang Y-C, Hsu C-C, Lin W-C et al (2014) Effects of metformin on the cerebral metabolic changes in type 2 diabetic patients. Sci World J 2014:1\u20138. https:\/\/doi.org\/10.1155\/2014\/694326","journal-title":"Sci World J"},{"key":"6405_CR47","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1368-504x.2004.00389.x","volume":"143","author":"RA DeFronzo","year":"2004","unstructured":"DeFronzo RA (2004) Dysfunctional fat cells, lipotoxicity and type 2 diabetes. Int J Clin Pract Suppl 143:9\u201321. https:\/\/doi.org\/10.1111\/j.1368-504x.2004.00389.x","journal-title":"Int J Clin Pract Suppl"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-025-06405-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-025-06405-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-025-06405-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T19:03:52Z","timestamp":1747076632000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-025-06405-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["6405"],"URL":"https:\/\/doi.org\/10.1007\/s00125-025-06405-7","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,11]]},"assertion":[{"value":"23 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors acknowledge B. MacIntosh (University of Toronto) for helpful discussions on ASL.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Acknowledgements"}},{"value":"The datasets generated and analysed in the current study are available from the corresponding author upon reasonable request.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"Antaros Medical funded the study with financial sponsorship from AstraZeneca.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"MS, EJ, IL, AFL, LJ and KH are employed by Antaros Medical. JO and RE are employed by AstraZeneca. The authors declare that there are no other relationships or activities that might bias, or be perceived to bias, their work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 relationships and activities"}},{"value":"MS and IL were involved in conduct, analysis and interpretation. EJ, ML, AG, TD, PN, RE, LJ, JO and KH were involved in the conception, design and conduct of the study and the analysis and interpretation of the results. AFL was involved in conception, design and conduct of the study. MS wrote the first draft of the manuscript and all authors edited, reviewed and approved the final version. MS is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the analyses.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Contribution statement"}}]}}